Laura F. Hutchins, MD Professor of Medicine Director, Division of Hematology/Oncology Virginia Clinton Kelly Endowed Chair for Clinical Breast Cancer Research

Medical Degree University of Arkansas for Medical Sciences Fellowship Training University of Arknasas for Medical Sciences, Hematology/Oncology Board Certification(s) Internal medicine Hematology Oncology Residencies University of Arkansas for Medical Sciences, Internal Medicine Clinical Interests Breast cancer Melanoma Research Interests Breast carcinoma Melanoma Geriatric oncology E-mail: BreastCancer@uams.edu

Research Overview:

Laura F. Hutchins, MD - Dr. Laura Hutchins is a Professor and the Director of the Division of Hematology/Oncology at the University of Arkansas for Medical Sciences. She is also the Director of Clinical Research for the Arkansas Cancer Research Center. 

Dr. Hutchins received her medical degree from the University of Arkansas for Medical Sciences and has worked as a medical oncologist at that institution since receiving her training. She has dedicated her nearly 30-year career to patient care, clinical research and teaching. As the Hem/Onc Division director she oversees an ACGME accredited fellowship program accommodating 9 fellows for a 3-year program. She has been honored twice with a "Top Doctor" award from Castle Connelly and has received awards for Outstanding Woman Faculty, Distinguished Faculty and Humanism in Medicine.

Dr. Hutchins has contributed to several textbooks and has more than 60 journal publications. Her research interests have focused primarily on melanoma, breast cancer, immunotherapy and biologic therapy for cancer. She currently presides over 15 open clinical trials sponsored by industry, and she is the designated Principal Investigator for all SWOG (Southwest Oncology Group) trials at the University of Arkansas for Medical Sciences. Dr. Hutchins' non-industry research efforts include a current Department of Defense grant to investigate the safety, tolerability and immune response associated with a breast cancer vaccine and an NCI project to allow adoption and testing of its caBIG C3D clinical trials database system. Recently Dr. Hutchins completed a 3-year federal HRSA grant to promote the use of telemedicine throughout Arkansas. 

Dr. Hutchins additionally shares her experience and expertise on statewide committees. At the appointment of the governor of Arkansas, Dr. Hutchins served as a member on the Arkansas Breast Cancer Research Program Oversight Committee from 2001-2004. In 2004, Dr. Hutchins was appointed by the governor to serve on the state Breast Cancer Control Advisory Board. In January, she became chairwoman of the group.

Selected Publications:

Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A, Murali R, Hutchins LF, Kieber-Emmons T. Preclinical Studies of Carbohydrate Mimetic Peptide Vaccines for Breast Cancer and Melanoma. Vaccine. 2007 Apr 20, 25(16):3022-31 (epub Jan 26).

Linden HM, Haskell CM, Green SJ, Osborne CK, Sledge GW Jr, Shapiro CL, Ingle JN, Lew D, Hutchins LF, Livingston RB, Martino S. Sequenced Compared with Simultaneous Anthracycline and Cyclophosphamide in High-Risk Stage I and II Breast Cancer: Final Analysis from INT-0137 (S9313). J Clin Oncol 2007 Feb 20;25(6):656-61.

Unger JM, Coltman JA, Crowley JJ, Hutchins LF, Martino S, Livingston RB, Macdonald JS, Blanke CD, Gandara DR, Crawford ED, Albain KS. Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials. J Clin Oncol 2006 Jan 1;24(1):141-4.

Safar M, O'Sullivan P, Ray L, Hutchins L, Mehta P. Editorial clubs as a new teaching tool in postgraduate training. J Cancer Educ 2006 21(3):163-165.

Gonzalez R, Hutchins L, Neumanaitis J, Atkins M, Scwarzenberger PO. Phase 2 Trial of Allovectin-7 in Advanced Metastatic Melanoma. Melanoma Res 2006; Dec 16(6):521-6.

Khalil O, Govindarajan R, Safar M, Hutchins L, Mehta P. Clinical Trial Registration and the ICMJE. J Amer Med Assoc 2005; 293(2):157.

Greene G, Gokden N, Hutchins L, Williams R. Metastatic Renal Cell Carcinoma to Prostate. Urology. 2005 Jun;65(6):1227.

Safar AM, Spencer H 3rd, Su X, Coffey M, Cooney CA, Ratnasinghe LD, Hutchins LF, Fan CY. Methylation Profiling of Archived Non-Small Cell Lung Cancer: A Promising Prognostic System. Clin Cancer Res. 2005 Jun 15:11(12):4400-5.

Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, Laufman L, Sundaram S, Urba WJ, Pritchard KI, Mennel R, Richards D, Olsen S, Meyers ML, Ravdin PM. Randomized Phase III Study of Docetaxel Compared with Paclitaxel in Metastatic Breast Cancer. J Clin Oncol Aug 20:23(24):5542-51, Aug 2005.

Hutchins LF, Green SJ, Ravdin PM, Lew D, Martino S, Abeloff M, Lyss AP, Allred C, Rivkin SE, Osborne CK. Randomized, Controlled Trial of Cyclophosphamide, Methotrexate, and Fluorouracil Versus Cyclophosphamide, Doxorubicin, and Fluorouracil With and Without Tamoxifen for High-risk, Node-Negative Breast Cancer: Treatment Results of Intergroup Protocol INT-0102. J Clin Oncol 2005 Nov 20;23(33):8313-21.